Mersana Therapeutics Layoffs - crm.catalystglobal.com 43fc72
Webjul 27, 2023 · the failure of mersana therapeutics’ lead ovarian cancer drug in a phase 1/2 trial has sent the biotech into a tailspin, resulting in layoffs affecting half of the employees in an effort to. Webjul 27, 2023 · mersana therapeutics, inc. (july 27, 2023) the worker adjustment and retraining notification (warn) act requires employers with 100 or more employees to.
Mersana fired fully half its staff in the interests of a “strategic reprioritization. ” reports from fierce biotech suggest that mersana will instead focus on. Webjul 27, 2023 · mersana therapeutics is down 78% in thursday trading after announcing that a pivotal trial for lead candidate upifitamab rilsodotin (upri) for ovarian cancer missed its. Webjul 27, 2023 · vast layoffs.